Hosted on MSN
Alpha Tau expands Alpha DaRT into recurrent prostate cancer: What investors should watch
Alpha Tau Medical Ltd (DRTS) announced an update on their ongoing clinical study. Study Overview – Alpha Tau Medical Ltd. (NASDAQ: DRTS) is launching a new safety study titled “A Safety Study of ...
All Penny Stocks (English) on MSN
Throwing precision darts: The company leading next evolution of cancer radiation
Radiation therapy has been a foundation of cancer care for more than a century. From early X-ray machines to today’s image-guided systems, the goal has remained the same: deliver enough energy to ...
CLEVELAND, Ohio — The Ohio State University’s James Cancer Hospital has treated the world’s first brain cancer patient to receive a new radiation technology that attacks tumors from within, the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback